MedPath

Razonam

Brand Name: Razonam

Generic Name: Cefoperazone (as sodium) + Sulbactam (as sodium)

Active
Registration Number

DR-XY47683

Dosage Form

Powder for Injection (I.M./I.V.)

Issuance Date

January 31, 2022

Expiry Date

January 31, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength1 g/500 mg
Packaging15 mL clear USP Type III clear glass vial, gray bromobutyl rubber stopper and red flip-off seal (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Cephalosporin)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Cefoperazone (as sodium)Active
Monograph: cefoperazone (as sodium)
Sulbactam (as sodium)Active

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform